You are here

NeuroStar

In October 2008, the FDA approved TMS Therapy using the NeuroStar Advanced Therapy brain-stimulating device for patients suffering from Major Depressive Disorder who have failed to receive satisfactory improvement from antidepressant medication in the current episode. Neuronetics pioneered clinical TMS practice in the US with over 850 systems placed. They played a pivotal role in educating the public and clinicians on TMS and advocating for insurance coverage across the country. NeuroStar was the first to receive FDA clearance for a 19-minute treatment time and they provide the most comprehensive practice support and service program guaranteeing 99% customer uptime.